CONSOLIDATED STATEMENTS OF EQUITY - USD ($)	Common Shares	Additional Paid in Capital	Accumulated Deficit	Noncontrolling Interest	Total
Balance at Sep. 30, 2020	$ 5,144	$ 275,548,737	$ (269,835,650)	$ (8,725)	$ 5,709,506
Balance (in shares) at Sep. 30, 2020	5,142,779
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of warrants	$ 521	2,613,408			2,613,929
Exercise of warrants (in shares)	520,151
Fair value of warrants issued in connection with convertible note repayment		1,643,440			1,643,440
Stock based compensation expense		1,668,003			1,668,003
Common stock issued in public offering, net of offering costs	$ 1,810	13,754,697			13,756,507
Common stock issued in public offering, net of offering costs (in shares)	1,810,000
Exercise of options cashlessly	$ 13	(13)
Exercise of options cashlessly (in shares)	13,190
Net loss			(14,286,442)	8,003	(14,278,439)
Balance at Sep. 30, 2021	$ 7,488	295,228,272	(284,122,092)	(722)	$ 11,112,946
Balance (in shares) at Sep. 30, 2021	7,486,120				7,486,120
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of warrants	$ 1,673	3,698,402			$ 3,700,075
Exercise of warrants (in shares)	1,674,200
Derecognition of warrant liability		2,802,879			2,802,879
Stock based compensation expense		2,518,665			2,518,665
Common stock issued in public offering, net of offering costs	$ 3,748	740,685			744,433
Common stock issued in public offering, net of offering costs (in shares)	3,748,200
Options issued in settlement of accrued bonus		300,000			300,000
Deemed dividend - warrant repricing		110,105	(110,105)
Net loss			(8,267,891)	(2,168)	(8,270,059)
Balance at Sep. 30, 2022	$ 12,909	$ 305,399,008	$ (292,500,088)	$ (2,890)	$ 12,908,939
Balance (in shares) at Sep. 30, 2022	12,908,520				12,908,520